微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 49.8% | -1.12% | -0.81% | 74/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 50.21% | -0.18% | -0.76% | 76/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 50.6% | 0.91% | 0.49% | 72/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 50.35% | 0.59% | -0.03% | 74/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 50.37% | 0.75% | 0.12% | 77/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 50.3% | 0.73% | 0.32% | 71/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 50.14% | -2.38% | 0.18% | 77/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 50.05% | -2.94% | 0.12% | 75/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 49.99% | -3.27% | 0.1% | 76/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 49.94% | -5.25% | -2.77% | 72/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 51.36% | 6.72% | -0.4% | 74/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 51.57% | 10.03% | -0.22% | 72/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 51.68% | 9.41% | -1.94% | 72/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 52.71% | 4% | 9.51% | 71/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 48.13% | -0.32% | 2.7% | 83/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 46.87% | -5.92% | -0.79% | 79/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 47.24% | -6.41% | -6.79% | 81/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 50.68% | -2.29% | 4.95% | 72/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 48.29% | -8.34% | -3.07% | 87/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 49.81% | -11.09% | -1.31% | 75/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 50.48% | -11.71% | -2.68% | 81/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 51.86% | -2.37% | -1.55% | 69/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 52.68% | 24.81% | -5.97% | 84/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 56.03% | 33.64% | -2% | 59/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 57.17% | 37.2% | 7.62% | 68/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 53.12% | 29.22% | 25.86% | 47/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 42.21% | 5.98% | 0.68% | 91/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 41.92% | 4.37% | 0.61% | 49/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 41.67% | 3.57% | 1.36% | 58/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 41.11% | -1.2% | 3.23% | 37/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 39.83% | 0.41% | -0.85% | 83/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 40.17% | -3.1% | -0.17% | 36/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 40.24% | -3.75% | -3.3% | 41/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 41.61% | 0.19% | 4.91% | 34/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 39.66% | 2.65% | -4.31% | 77/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 41.45% | 3.45% | -0.85% | 31/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 41.8% | 2.36% | 0.65% | 40/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 41.53% | 1.52% | 7.49% | 31/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 38.64% | -2.97% | -3.56% | 62/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 40.07% | -1.05% | -1.89% | 29/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 40.84% | -1.26% | -0.18% | 34/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 40.91% | -2.36% | 2.74% | 21/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |